Bellevue Group Ag Dexcom Inc Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Dexcom Inc stock. As of the latest transaction made, Bellevue Group Ag holds 1,017,038 shares of DXCM stock, worth $81.6 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

1,017,038

Previous 1,268,687 19.84%

Holding current value

$81.6 Million

Previous $144 Million 52.61%

% of portfolio

1.15%

Previous 2.41%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $16.1 Million - $29.2 Million	-251,649 Reduced 19.84%	1,017,038 $68.2 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $5.24 Million - $6.67 Million	47,490 Added 3.89%	1,268,687 $144 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $35 Million - $43 Million	306,604 Added 33.52%	1,221,197 $169 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $17.3 Million - $28.4 Million	228,860 Added 33.37%	914,593 $113 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $6.54 Million - $10.5 Million	-75,983 Reduced 9.98%	685,733 $64 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $746,463 - $869,314	6,637 Added 0.88%	761,716 $97.9 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $24.3 Million - $28.7 Million	-233,397 Reduced 23.61%	755,079 $87.7 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $10.9 Million - $15.7 Million	128,016 Added 14.88%	988,476 $112 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $5.2 Million - $6.41 Million	-68,048 Reduced 7.33%	860,460 $69.3 Million
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $47.2 Million - $92.2 Million	693,608 Added 295.28%	928,508 $69.2 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $23,802 - $32,940	-253 Reduced 0.11%	234,900 $120 Million
Q4 2021 Feb 10, 2022	SELL	$129.87 - $162.82 $3.73 Million - $4.67 Million	-28,686 Reduced 10.87%	235,153 $126 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $2.03 Million - $2.73 Million	19,063 Added 7.79%	263,839 $144 Million
Q2 2021 Aug 12, 2021	BUY	$80.99 - $107.93 $2.31 Million - $3.08 Million	28,583 Added 13.22%	244,776 $105 Million
Q1 2021 May 12, 2021	BUY	$84.79 - $104.74 $244,703 - $302,279	2,886 Added 1.35%	216,193 $77.7 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $7.14 Million - $9.57 Million	91,602 Added 75.27%	213,307 $78.9 Million
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $1.81 Million - $2.15 Million	19,000 Added 18.5%	121,705 $50.2 Million
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $86,310 - $145,053	1,377 Added 1.36%	102,705 $41.6 Million
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $1.09 Million - $1.73 Million	22,853 Added 29.12%	101,328 $27.3 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $3.31 Million - $5.18 Million	-90,412 Reduced 53.53%	78,475 $17.2 Million
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $133,273 - $164,293	3,751 Added 2.27%	168,887 $25.2 Million
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $946,281 - $1.32 Million	33,990 Added 25.92%	165,136 $24.7 Million
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $1.5 Million - $2.04 Million	53,338 Added 68.55%	131,146 $15.6 Million
Q4 2018 Feb 12, 2019	BUY	$26.99 - $37.37 $166,285 - $230,236	6,161 Added 8.6%	77,808 $9.32 Million
Q3 2018 Nov 13, 2018	SELL	$23.35 - $36.72 $4.65 Million - $7.32 Million	-199,250 Reduced 73.55%	71,647 $10.2 Million
Q2 2018 Aug 07, 2018	SELL	$17.54 - $25.22 $1.5 Million - $2.16 Million	-85,493 Reduced 23.99%	270,897 $25.7 Million
Q1 2018 May 09, 2018	BUY	$13.06 - $18.54 $1.17 Million - $1.66 Million	89,650 Added 33.61%	356,390 $26.4 Million
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $2.47 Million - $3.41 Million	221,740 Added 492.76%	266,740 $15.3 Million
Q3 2017 Nov 13, 2017	BUY	$11.36 - $18.98 $85,200 - $142,350	7,500 Added 20.0%	45,000 $2.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	37,500	37,500 $2.74 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Dexcom Inc Transaction History